>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Summary:

Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

ASA Submits Comments to CMS Regarding the CY 2011 Physician Fee Schedule Final Rule

Monday, January 03, 2011

On January 3, ASA submitted comments to CMS regarding the Physician Fee Schedule final rule for CY 2011.  ASA requested that CMS provide clarification on the methodology and calculations used to derive the 2011 anesthesia conversion factor and urged CMS to accept the AMA Relative Value Unit Committee’s (RUC) recommended work values for transforaminal epidural injections.

Please click here to view the comment letter.

« Back to Washington Alerts